In the News
Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes
The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
Study finds ‘marked improvements’ in diabetes management from 1999 to 2016
While the proportion of U.S. adults with diabetes who attained glycemic, blood pressure, and lipid control increased during the study period, there was a lack of progress related to dietary guidelines.
HbA1c level may predict cardiovascular events in high-risk patients with diabetes
Glycemic control as measured by HbA1c level remains strongly and independently associated with cardiovascular outcomes in high-risk patients with diabetes on statin therapy.
MKSAP quiz: Meeting HbA1c goals in type 2 diabetes
This month's quiz asks readers to treat a patient with type 2 diabetes who is taking insulin detemir, prandial insulin lispro, and metformin and wishes to reduce his HbA1c level to below 7%.
Spotlight on type 1 diabetes in older adults
One recent study in older patients with type 1 diabetes found an association between a recent history of severe hypoglycemia and impaired cognition, while another suggested that continuous subcutaneous insulin infusions are safe and effective in this population.
FDA authorizes marketing of first interoperable, automated insulin dosing controller
The device automatically adjusts insulin delivery to a person with diabetes by connecting to an alternate controller-enabled insulin pump and integrated continuous glucose monitor.
In acute ischemic stroke with hyperglycemia, intensive vs standard glucose control did not improve 90-day outcomes
Several factors, including high rates of reperfusion therapy and early hospital discharge, may explain why this trial found no benefit from intensive glucose control after stroke, according to an ACP Journal Club commentary.
SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists
An ACP Journal Club commentary called the results of this real-world, retrospective study reassuring regarding concerns about associations of urinary tract infections (UTIs) with sodium-glucose cotransporter-2 (SGLT-2) inhibitors.